Phase I study of sunitinib (SU) in combination with pemetrexed (Pem) in patients (pts) with advanced solid tumors (ST)

被引：0
|
作者：
Nakagawa, K. [1 ,2 ]
Okamoto, I. [1 ,2 ]
Shimizu, T. [1 ,2 ]
Miyazaki, M. [1 ,2 ]
Tsurutani, J. [1 ,2 ]
Ichikawa, Y. [1 ,2 ]
Terashima, M. [1 ,2 ]
Takeda, M. [1 ,2 ]
Fumita, S. [1 ,2 ]
Kiriyama, T. [1 ,2 ]
机构：
[1] Kinki Univ, Sch Med, Osaka 589, Japan
[2] Pfizer Japan Inc, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14630
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I study of sunitinib (SU) in combination with pemetrexed (Pem) in patients (pts) with advanced solid tumors (ST)
    Nakagawa, Kazuhiko
    Okamoto, Isamu
    Shimizu, Toshio
    Miyazaki, Masaki
    Tsurutani, Junji
    Ichikawa, Yasuko
    Terashima, Masaaki
    Takeda, Masayuki
    Fumita, Soichi
    Kiriyama, Tsukasa
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S701 - S701
  • [2] A PHASE I DOSE ESCALATION STUDY OF SUNITINIB (SU) IN COMBINATION WITH PEMETREXED (PEM) IN PATIENTS (PTS) WITH ADVANCED SOLID MALIGNANCIES
    Chow, L. Q. M.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2008, 19 : 159 - 159
  • [3] Sunitinib (SU) in combination with pemetrexed (P) in patients (pts) with advanced solid malignancies: A phase I dose escalation study
    Chow, L. Q.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    Goss, G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A phase I dose-finding study of sunitinib (SU) in combination with gemcitabine (G) in patients (pts) with advanced solid tumors
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D. P.
    McDermott, D. F.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] A PHASE I DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH GEMCITABINE (G) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D.
    McDermott, D.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [6] Phase I tolerability/safety of sunitinib in combination with capecitabine in patients (pts) with advanced solid tumors
    Verschraegen, C.
    Sweeney, C.
    Chiorean, G.
    Lee, F. C.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    EJC SUPPLEMENTS, 2007, 5 (04): : 111 - 111
  • [7] Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors
    Isamu Okamoto
    Toshio Shimizu
    Masaki Miyazaki
    Junji Tsurutani
    Yasuko Ichikawa
    Masaki Terashima
    Masayuki Takeda
    Soichi Fumita
    Emiko Ohki
    Nobuyuki Kimura
    Junichi Hashimoto
    Kazuhiko Nakagawa
    Investigational New Drugs, 2012, 30 : 639 - 646
  • [8] Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors
    Okamoto, Isamu
    Shimizu, Toshio
    Miyazaki, Masaki
    Tsurutani, Junji
    Ichikawa, Yasuko
    Terashima, Masaki
    Takeda, Masayuki
    Fumita, Soichi
    Ohki, Emiko
    Kimura, Nobuyuki
    Hashimoto, Junichi
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 639 - 646
  • [9] A phase I study of bevacizumab in combination with sunitinib in advanced solid tumors
    Cooney, M. M.
    Garcia, J.
    Brell, J.
    Dreicer, R.
    Beatty, K.
    Mekhail, T.
    Bukowski, R.
    Zwiebel, J.
    Remick, S. C.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Phase I safety and pharmacokinetic (PK) study of sunitinib (S) in combination with ifosfamide (I) in patients (pts) with advanced solid tumors (STs)
    Hamberg, P.
    Steeghs, N.
    Loos, W. J.
    van der Biessen, D. J.
    den Hollander, M. A.
    Tascilar, M.
    Verweij, J.
    Gelderblom, H.
    Sleijfer, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345